RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 6.562
EU - Europa 6.525
AS - Asia 4.072
SA - Sud America 516
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 5
Totale 17.734
Nazione #
US - Stati Uniti d'America 6.481
CN - Cina 1.728
IE - Irlanda 1.645
SG - Singapore 1.229
UA - Ucraina 1.099
SE - Svezia 853
IT - Italia 833
DE - Germania 589
RU - Federazione Russa 499
BR - Brasile 450
FI - Finlandia 372
HK - Hong Kong 370
FR - Francia 280
IN - India 270
TR - Turchia 246
GB - Regno Unito 140
VN - Vietnam 101
CZ - Repubblica Ceca 57
CA - Canada 51
NL - Olanda 39
BE - Belgio 31
JP - Giappone 25
AT - Austria 24
ES - Italia 23
MX - Messico 21
ZA - Sudafrica 16
PL - Polonia 15
BD - Bangladesh 14
AR - Argentina 13
EC - Ecuador 13
CL - Cile 11
LT - Lituania 11
PK - Pakistan 11
PY - Paraguay 10
EU - Europa 9
IQ - Iraq 9
VE - Venezuela 8
ID - Indonesia 7
MA - Marocco 7
PH - Filippine 7
IR - Iran 6
UZ - Uzbekistan 6
CO - Colombia 5
IL - Israele 5
JO - Giordania 5
MY - Malesia 5
RO - Romania 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
KE - Kenya 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
NZ - Nuova Zelanda 3
OM - Oman 3
UY - Uruguay 3
AU - Australia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
NP - Nepal 2
PE - Perù 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.734
Città #
Dublin 1.645
Chandler 999
Jacksonville 772
Nyköping 548
Dearborn 541
Singapore 530
Munich 412
Ashburn 401
Nanjing 380
Hong Kong 365
Beijing 313
Dallas 242
Wilmington 239
New York 224
Santa Clara 212
Helsinki 203
Princeton 179
San Mateo 157
Nanchang 145
Ann Arbor 122
Boardman 119
Foggia 98
Moscow 96
Shenyang 84
Woodbridge 83
Bari 73
Des Moines 73
The Dalles 69
Tianjin 69
Hebei 68
Los Angeles 68
Milan 55
Brno 53
Seattle 53
Kunming 51
Rome 46
Jiaxing 45
Changsha 43
Pune 36
Ho Chi Minh City 35
São Paulo 35
Hangzhou 33
Jinan 30
Brussels 29
Falls Church 29
Guangzhou 28
Shanghai 28
Brooklyn 25
Hilden 25
Zhengzhou 25
Ningbo 23
Toronto 23
San Francisco 22
Tokyo 22
Augusta 20
Hanoi 18
London 18
Noci 17
Norwalk 17
Rio de Janeiro 17
Taizhou 17
Changchun 16
Lanzhou 16
Fuzhou 15
Stevenage 15
Belo Horizonte 14
Auburn Hills 13
Houston 13
Manfredonia 13
Chicago 12
Naples 12
Warsaw 12
Nuremberg 11
Turku 11
Vienna 11
Boston 10
Catania 10
Florence 10
Phoenix 10
Saint Petersburg 10
Falkenstein 9
Johannesburg 9
Jyväskylä 9
Leawood 9
Orange 9
Rotterdam 9
Shenzhen 9
Wuhan 9
Atlanta 8
Bologna 8
Düsseldorf 8
Latina 8
Manchester 8
Molfetta 8
Redwood City 8
Stockholm 8
Washington 8
Acquaviva Delle Fonti 7
Bisceglie 7
Brasília 7
Totale 10.846
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 407
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 255
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 250
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 234
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 223
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 164
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 148
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 146
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 146
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 144
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 143
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 142
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 141
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 140
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 138
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 135
cell carcinoma cell line and use thereof. 133
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 131
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 131
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 127
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 126
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 123
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 123
IgA nephropathy: pros and cons for a familial disease. 122
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 122
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 121
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 121
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 121
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 119
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 119
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 118
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 118
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 118
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 116
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 116
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 115
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 115
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 114
Renal Carcinoma Cell Line and Use Thereof 113
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 113
Renal cortical complement C3 gene expression in IgA nephropathy 113
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 110
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 109
Biosimilar: can we manage biopharmaceutical heterogeneity? 109
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 109
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 109
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 108
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 105
Reclassification of glomerulopathies: which role for the podocyte? 105
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 105
Linea cellulare di carcinoma renale e suo uso 105
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 105
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 104
Renal and upper urinary tract tumors: what the nephrologist should know 103
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 103
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 103
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 103
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 103
Altered expression of the clock gene machinery in kidney cancer patients 103
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 102
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 102
Salivary proteomic signatures of oral squamous cell carcinoma. 102
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 102
Is Berger's disease a hereditary nephritis? 101
Urinary epidermal growth factor concentration in patients affected by ADPKD. 101
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 101
Diagnostic and prognostic markers of renal cell carcinoma 101
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 100
Immunologic Response to RCC. 100
Growth factors and their receptors in the progression of renal damage. 100
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 100
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 98
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 98
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 98
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 96
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 96
Cytotoxic T-Cells Methods and Protocols Preface 96
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 95
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 94
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 94
Monitoring biological action of rapamycin in renal transplantation. 94
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 94
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 93
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 93
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 92
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 92
CD40 cross-linking induces migration of renal tumor cell through nuclear factor of activated T cells (NFAT) activation 92
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 91
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 91
Diabetes Mellitus (DM) reduces survival in patients with renal cell carcinoma (RCC) : role of OGG1 and tuberine 91
TLR7 and TLR8 as targets for tumor immunotherapy 91
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 90
TGF-β promotes immune suppression by inhibiting Treg cell apoptosis 90
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 90
CTL ELISPOT AssayCytotoxic T-Cells 90
Platelet-derived growth factor and proliferative glomerulonephritis. 89
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 89
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 89
VHL gene alterations in Italian patients with isolated renal cell carcinomas. 89
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 89
Totale 11.761
Categoria #
all - tutte 100.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.138 0 0 0 0 180 114 222 43 295 263 17 4
2021/20221.139 157 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20253.415 196 47 113 103 125 454 484 268 815 175 335 300
2025/20262.147 325 511 559 693 59 0 0 0 0 0 0 0
Totale 18.244